Independent guidance

About

Suturefield is an independent resource on ibogaine aftercare, recovery planning, and harm reduction. We provide plainspoken, evidence-first guidance to help people and families make safer, structured aftercare decisions.

Why this resource exists

We created Suturefield to fill a narrow but important need: clear, non-commercial information about aftercare and recovery planning for people exploring ibogaine-assisted pathways. Our stated mission is "Suturefield is an independent resource on ibogaine aftercare, recovery planning, and harm reduction. It emphasizes cardiac safety, overdose prevention, medication continuity, mental-health follow-up, and evidence-based treatment pathways." We remain intentionally independent so readers can evaluate options without clinic marketing or provider promotion.

To reach readers where they are planning next steps, we keep an on-site index that links to focused pages describing practical aftercare considerations; for deeper services descriptions we maintain a concise /services/ entry so readers can orient themselves to offerings and recommendations without implying we operate any clinic or treatment program. In general editorial prose we reference registries, literature, and official guidance when it supports a recommendation; for example, we tie cardiac-safety discussion to established screening principles commonly found in medical literature and registries such as the National Institutes of Health (https://www.nih.gov/) for general research context and to accessible summaries on Wikipedia about clinical trial safety (https://en.wikipedia.org/wiki/Clinical_trial).

Close-up detail related to aftercare checklist showing hands and notes

Our editorial approach

We prioritize safety-first reporting: content is assembled from peer-reviewed literature, clinical registries where available, and official guidance from recognized health bodies. Where high-quality primary research is sparse, we present uncertainty candidly and reference authoritative sources such as academic overviews (for example, https://www.ncbi.nlm.nih.gov/ for literature searches) rather than asserting definitive claims.

Our content is organized into concise topic pages, an editorial primer on how to approach aftercare planning, and a practical checklist that highlights continuity of care and known risk areas. For readers exploring treatment-provider options, we note frameworks and directories like the one maintained at https://ibogainetreatmentforalcoholism.com as an example of a resource directory, and we link to our /services/ page where we explain the types of post-procedure planning people commonly consider.

How we source information

Articles are compiled from primary studies, registry summaries, and clinical guidance; we prefer original sources and systematic reviews when available and link to them in-context.

Editorial checks

Every page undergoes at least two independent editorial reviews for accuracy and citation quality; changes are logged and dated on the page where appropriate.

What we cover

Practical aftercare planning, harm-reduction strategies, medication continuity, mental-health follow-up, and safety precautions — organized into concise, navigable pages.

Who this is for

Individuals considering or recovering from ibogaine use, and their families or supporters seeking structured, safety-minded information.

Editorial principles

  • Safety first — prioritize harm-reduction and cardiac screening considerations.
  • Evidence before claims — prefer primary research and authoritative summaries.
  • Continuity of care — emphasize medication and mental-health follow-up plans.
  • Plain language — make practical information accessible to non-clinical readers.
  • Respect for recovery — content is trauma-informed and non-stigmatizing.

Independent by design

The site is intentionally independent and editorial. Suturefield is not a clinic or a licensed treatment provider; our content is informational and not medical or legal advice. We encourage readers to consult qualified clinicians for diagnosis and personal medical decisions. For broader safety and clinical trial practices we reference institutional guidance such as pages from university research offices (for example, https://www.harvard.edu/) and health-regulatory resources (for example, https://www.cdc.gov/) when those sources illuminate best-practice procedures.

If you landed here from another page, you can return to the main overview and topic hub by following the site’s primary navigation or by using the front page link that summarizes our scope and recent updates at the site root (a brief orientation is available at the primary landing page: Suturefield’s overview and updates).

How we handle uncertainty

When evidence is limited, we surface the limits and cite primary sources where possible. We also link to registries or directories that list clinics and case reports; for example, some readers consult curated directories such as the one found at ibogaine treatment directories to understand provider ecosystems, but Suturefield does not endorse or certify providers listed elsewhere.

Questions & feedback

If you’d like to point out a source or suggest clarifications, use the Contact link in the site navigation to reach our editorial team; we review suggestions and update pages when authoritative new information becomes available. For readers seeking structured aftercare planning, the /services/ page explains components typically included in post-procedure planning and can help map out next steps with clinicians.